-- 美國週二表示,已起草聯合國安理會決議草案,旨在維護霍爾木茲海峽的航行自由。美國指責伊朗透過攻擊、布雷和試圖向商船徵收通行費等手段威脅全球航運。 美國國務卿馬可·盧比奧在一份聲明中表示,伊朗在這一戰略水道上的行動“挾持了世界經濟”,而全球石油和天然氣貿易很大一部分都經由該水道進行。 這份與包括巴林、沙烏地阿拉伯、阿聯酋、科威特和卡達在內的地區夥伴共同起草的決議草案,呼籲德黑蘭停止攻擊、停止布雷,並放棄任何向商船徵收通行費的企圖。 美國及其盟友也要求伊朗揭露其佈設水雷的數量和位置,並配合清除水雷。 該提案還支持建立一條人道主義海上走廊。 盧比歐國務卿表示,美國預計該決議將在未來幾天內進行表決,並表示有信心獲得安理會成員和其他共同提案國的支持。 然而,據報道,該倡議前景不明朗,因為它需要俄羅斯和中國的支持,而這兩個國家作為安理會常任理事國都擁有否決權。
Related Articles
Simcere Pharmaceutical Receives Chinese Regulatory Approval to Begin Trials of Tumor Drug
Simcere Pharmaceutical (HKG:2096) received Chinese regulatory approval to begin clinical trials of SIM0613, according to a Hong Kong bourse filing Wednesday.The injection is intended to treat advanced solid tumors and is licensed to Ipsen Pharma in regions outside Greater China.
Meitu Records 30% Rise in Paying Subscribers
Meitu (HKG:1357) said the number of paying subscribers using its platform grew 30% year on year to 17.90 million as of end March, according to a Hong Kong bourse filing Wednesday.Paying subscribers for the company's productivity tools grew 53% to 2.34 million, while leisure app subscribers increased 27% to 15.56 million, the firm said.The company's core revenue grew 34.3% year on year to 852 million yuan, while other businesses remained "stable overall."The company's annual recurring revenue for AI-driven productivity apps stood at 580 million yuan as of March, a 56% increase from a year earlier.
Yidu Tech Unit Wins SG$2.3 Million Singapore Healthcare Project
Yidu Tech (HKG:2158) said its subsidiary EVYD Research Private Limited won a contract from Singapore Health Services for the implementation and support of Dr Buddy, according to a Wednesday Hong Kong bourse filing.The total project amount is about SG$2.3 million.